Orasure Technologies, Inc. · NASDAQ:OSUR

Orasure Technologies — Merger or Acquisition (January 2024)

12 slides from Orasure Technologies's merger presentation, Jan 4, 2024

  1. Slide 1: Strategic Partnership & Investment in Sapphiros

    OraSure Technologies, Inc. STRATEGIC PARTNERSHIP & INVESTMENT IN SAPPHIROS JANUARY 4, 2024 Exhibit 99.1

  2. Slide 2: Forward-Looking Statements

    © 2024 OraSure Technologies, Inc. 2 This presentation contains certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including with respect to products, product development and manufacturing activities, the investment of OraSure Technologies

  3. Slide 3: Executive Summary

    © 2024 OraSure Technologies, Inc. 3 Executive Summary Strategic Alignment • OTI enters strategic relationship with Sapphiros, securing exclusive distribution rights to a select portfolio of key products in development that address opportunities and needs in our current portfolio o Sample management

  4. Slide 4: Strategic Transformation & Financial Impact

    © 2024 OraSure Technologies, Inc. 4 Strategic Transformation & Financial Impact Partnership with Sapphiros is expected to accelerate profitable growth • Sales of Sapphiros products are expected to add at least 2 percentage points of revenue growth for our Core business beginning in 2025 o Initial pr

  5. Slide 5: Aligned in Vision & Mission

    © 2024 OraSure Technologies, Inc. 5 Aligned in Vision & Mission Transforming health through actionable insight: powering the shift that connects people to healthcare wherever they are Improving access, quality, and value of healthcare with innovation in effortless tests, sample management solutions

  6. Slide 6: Shared Focus on the Future of Healthcare

    © 2024 OraSure Technologies, Inc. 6 Move to Point-of-Care & Home Testing Growth of Precision Medicine Healthcare Consumerism OraSure’s Imperatives Shared Focus on the Future of Healthcare

  7. Slide 7: OTI Portfolio - Sample Management Solutions

    © 2024 OraSure Technologies, Inc. 7 Analytes (ex. proteins) Sample Types (ex. blood) Partnership with Sapphiros expected to expand our offerings with new sample type (blood) New & expanded offerings – sample types, analytes, applications & clearances Leading tools & chemistries to collect, stabilize

  8. Slide 8: OTI Portfolio – Diagnostics

    © 2024 OraSure Technologies, Inc. 8 OTI Portfolio – Diagnostics Broad array of infectious disease – respiratory & sexual health – assays, ex. COVID-19, HIV, HCV Substance abuse testing OTI Diagnostics Actionable POC & self-testing increases affordability & access to care Clinical lab molecular Incre

  9. Slide 9: Sapphiros Developing Multiple New Technology Platforms

    © 2024 OraSure Technologies, Inc. 9 Sapphiros Developing Multiple New Technology Platforms … Innovation spanning the value chain focused on low cost, high-performance solutions at scale o Key capabilities: Automated manufacturing is highly scalable, leverages printed electronics to produce extremely

  10. Slide 10: Sapphiros' Innovation Builds upon OTI Strengths

    © 2024 OraSure Technologies, Inc. 10 Sapphiros’ Innovation Builds upon OTI Strengths … Attractive Paths to Growth Sample Management • Self-collected blood Lateral Flow Diagnostics (Visual & Digital) • Low-cost infectious diseases … + others to unlock segments  Expanded portfolio of offerings  Cust

  11. Slide 11: Leverages OTI's Existing Commercial Strengths & Expands Opportunities

    © 2024 OraSure Technologies, Inc. 11 Public Health Clinical Settings Self-Testing OraSure’s ImperativesLeverages OTI’s Existing Commercial Strengths & Expands Opportunities in New & Existing Segments  Expands OTI’s portfolio of high-performance sample management solutions and diagnostic tests  Sap

  12. Slide 12: Partnership with Sapphiros Supports Key Elements for Long-Term Success

    © 2024 OraSure Technologies, Inc. 12 Partnership with Sapphiros Supports Key Elements for Long-Term Success Key Elements Partnership Opportunities Product portfolio & pipeline • Comprehensive portfolio increases diversity & breadth of solutions spanning sample management & diagnostic testing • Low-c

Orasure Technologies — Merger or Acquisition (January 2024) on 6ix